Granahan Investment Management LLC grew its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 132.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 188,763 shares of the scientific and technical instruments company's stock after purchasing an additional 107,389 shares during the quarter. Granahan Investment Management LLC owned approximately 2.03% of Transcat worth $19,960,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Jones Financial Companies Lllp boosted its position in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after acquiring an additional 309 shares during the last quarter. Aquatic Capital Management LLC boosted its position in shares of Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after purchasing an additional 1,052 shares in the last quarter. Morgan Dempsey Capital Management LLC acquired a new stake in Transcat during the fourth quarter worth approximately $143,000. SG Americas Securities LLC bought a new stake in Transcat in the fourth quarter worth approximately $182,000. Finally, KLP Kapitalforvaltning AS bought a new stake in Transcat in the fourth quarter worth approximately $190,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.
Transcat Stock Up 0.5%
Shares of TRNS stock traded up $0.43 during trading hours on Thursday, reaching $79.72. The company had a trading volume of 118,187 shares, compared to its average volume of 77,619. The business has a fifty day simple moving average of $77.27 and a 200-day simple moving average of $90.40. Transcat, Inc. has a 12 month low of $67.56 and a 12 month high of $147.12. The company has a market cap of $742.11 million, a price-to-earnings ratio of 43.10 and a beta of 0.69. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on TRNS. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. HC Wainwright reduced their price target on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a report on Wednesday, January 29th. StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Finally, Northland Securities restated a "market perform" rating and issued a $85.00 target price (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $111.50.
Get Our Latest Analysis on TRNS
Transcat Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More

Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.